Fennec Announces Results of Annual Meeting

Published June 10, 2026 · Category: Markets

Overview

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify">RESEARCH TRIANGLE PARK, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the "Company") (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026...

Source

Originally published at markets.businessinsider.com.

Related Articles

• ERock CEO John Carrington reveals why it chose to go public now
• PureCycle Announces Proposed Concurrent Public Offerings of Convertible Senior Notes and Common Stock
• Capstone Infrastructure Corporation Provides Notice of Conversion Rights for Cumulative 5-Year Rate Reset Preferred Shares, Series A